跳至主要内容
临床试验/NL-OMON55342
NL-OMON55342已完成不适用

Carbohydrate induced resilience of the gut microbiome after antibiotics use - The CARMA study

niversiteit Maastricht0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Healthy overweight/obese (BMI: 25-40 kg/m^2) Caucasian adults (age: 20-65
  • years), male and female, with a stable body weight (< 3 kg change) for the last

排除标准

  • - Known allergic reaction to vancomycin or other glycopeptide antibiotics;
  • - Pre-diabetes, diabetes mellitus, cardiovascular disease, kidney disease,
  • hearing disorders, cancer, asthma or bronchitis, liver malfunciton, diseases
  • affecting glucose tolerance, major illness with a life expectancy < 5 years,
  • gastrointestinal disease or abdominal surgery,
  • - Abuse of products; alcohol and drugs, excessive nicotine use defined as > 20
  • cigarettes per day;
  • - Regular use of laxation products;
  • - Use of antibiotics in the past 3 months;
  • - Regular supplementation of pre- or probiotics products, use of pre- or
  • probiotics 3 months prior to the start of the study;
  • - Plans to lose weight or currently following a hypocaloric diet;
  • - Following a vegan diet;
  • - Participation in organized sports activities for > 3 hours per week.
  • - Suffering from hearing loss or other hearing problems.
  • - Currently pregnant, planning to become pregnant or currently breastfeeding.

研究者

相似试验